Virtual Surgery Company Has Raised $20 Million

7
b2b

A startup that provides a platform that enables surgeons to practice virtual surgeries in a safe setting has secured $20 million in venture funding.

London-based FundamentalVR said that the Series B financing will finance technological development and expansion in the US.

“Our platform can conduct a walkthrough of a procedure through to a full operation, facilitating surgical skills transfer,” FundamentalVR Co-Founder and Chief Executive Richard Vincent said in a prepared statement. “This is why we have been enthusiastically embraced throughout the medical industry, from med-device manufacturers to pharmaceuticals.” Our immersive environments change the learning of surgical skills in a scalable, affordable, multiuser method. We are eager to realize our goal of establishing an atmosphere free from barriers to medical education.

According to the release, Downing Ventures and EQT Life Sciences participated in the most recent round, which brought the total amount of venture capital invested in FundmentalVR to $30 million. Drew Burdon, an EQT Life Sciences Partner, will join FundamentalVR’s board of physicians as part of the deal.

Burdon stated in the release that it is crucial to offer medical practitioners new techniques for surgical skill transfer and ongoing training and education while controlling the expense and time burden associated with these efforts. “HapticVR is a differentiated strategy that has quickly attracted a number of high-quality clients, proving the value that this technology can provide right now.”

Chris Scattergood joined Vincent in founding FundamentalVR in 2001. “The HapticVR technology simulates the physical touch of surgical activities using virtual reality and haptics through data, artificial intelligence, and multimodal learning. According to the release, surgeons may participate in this initiative from anywhere in the world and provide students a realistic surgical experience.

According to FundamentalVR, the virtual instruction is accessible in more than 30 nations. Some have questioned whether regulation is keeping up with innovation in the field of healthcare technology, which has been a hot subject.